State
of New York
|
1-10113
|
11-0853640
|
(State
of Other Jurisdiction
|
(Commission
File Number)
|
(I.R.S.
Employer
|
of
Incorporation)
|
Identification
Number)
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
(17CFR240.14d 2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR
240.13e 4(c))
|
Exhibit
Number
|
Description
|
99.1
|
Press
Release dated May 4, 2007 Announcing Financial Results for the First
Quarter of 2007
|
ACURA
PHARMACEUTICALS, INC.
|
||
By:
|
/s/
Peter A. Clemens
|
|
Peter
A. Clemens
|
||
Senior
Vice President & Chief Financial
Officer
|
Exhibit
Number
|
Description
|
99.1
|
Press
Release dated May 4, 2007 Announcing Financial Results for the First
Quarter of 2007
|